SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-04-25 14:08
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$80,423
+14,060 vol
$5.72 each
44,830
Filed 2024-04-16 18:28
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$79,805
+14,001 vol
$5.70 each
Filed 2024-04-16 18:31
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$27,525
+4,829 vol
$5.70 each
12,085
Filed 2024-04-16 18:30
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$55,044
+9,657 vol
$5.70 each
24,171
Filed 2024-04-16 18:28
Tx date 2024-04-12
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$79,805
+14,001 vol
$5.70 each
44,771
Filed 2024-04-05 16:02
Tx date 2024-04-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$23,304
+4,397 vol
$5.30 each
4,397
Filed 2024-04-05 16:00
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-04-05 15:56
Tx date 2024-04-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
57 - Exercise of rights
$-21,064.03
-4,043 vol
$5.21 each
14,514
Filed 2024-04-05 15:54
Tx date 2024-04-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
57 - Exercise of rights
$-10,534.62
-2,022 vol
$5.21 each
7,256
Filed 2024-04-05 15:44
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$21,064
+4,043 vol
$5.21 each
4,043
Filed 2024-04-05 15:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$10,534
+2,022 vol
$5.21 each
2,022
Filed 2022-09-15 09:44
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$21,064
+4,043 vol
$5.21 each
Filed 2022-09-15 09:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$10,534
+2,022 vol
$5.21 each
Filed 2022-04-27 10:24
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2022-04-27 10:23
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2022-01-06 16:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2022-01-06 16:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2021-12-10 13:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2023-04-03 21:46
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$18,949
+4,268 vol
$4.44 each
11,299
Filed 2023-04-03 21:44
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$37,908
+8,538 vol
$4.44 each
16,536
Filed 2023-04-03 21:43
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$61,054
+13,751 vol
$4.44 each
30,770
Filed 2022-09-15 09:47
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$15,567
+2,988 vol
$5.21 each
7,031
Filed 2022-09-15 09:46
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$31,134
+5,976 vol
$5.21 each
7,998
Filed 2022-09-15 09:44
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$21,064
+4,043 vol
$5.21 each
4,043
Filed 2022-09-15 09:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$10,534
+2,022 vol
$5.21 each
2,022
Filed 2022-09-15 09:27
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$53,131
+10,198 vol
$5.21 each
17,019
Filed 2022-09-15 09:25
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$35,878
+6,821 vol
$5.26 each
6,821
Filed 2022-04-27 10:24
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2022-04-27 10:23
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2022-03-29 11:32
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$18,683
+3,586 vol
$5.21 each
Filed 2022-03-29 11:31
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$37,360
+7,171 vol
$5.21 each
Filed 2022-03-29 11:30
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$63,759
+12,238 vol
$5.21 each
Filed 2022-01-06 21:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$43,053
+8,185 vol
$5.26 each
Filed 2022-01-06 16:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2022-01-06 16:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2022-01-06 15:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2021-12-10 13:53
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2021-12-10 13:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2021-12-10 13:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2022-04-27 10:24
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
4,852
Filed 2022-04-27 10:23
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
2,426
Filed 2022-01-06 16:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2022-01-06 16:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2021-12-10 13:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2022-03-29 11:32
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$18,683
+3,586 vol
$5.21 each
6,012
Filed 2022-03-29 11:31
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$37,360
+7,171 vol
$5.21 each
12,023
Filed 2022-03-29 11:30
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$63,759
+12,238 vol
$5.21 each
20,423
Filed 2022-01-06 21:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$43,053
+8,185 vol
$5.26 each
8,185
Filed 2022-01-06 16:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
4,852
Filed 2022-01-06 16:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
2,426
Filed 2022-01-06 15:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2022-01-06 15:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
8,888
Filed 2021-12-10 13:53
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2021-12-10 13:53
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2021-12-10 13:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2021-12-10 13:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:53
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
8,888
Filed 2021-12-10 13:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
2,426
Filed 2021-12-10 13:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
4,852
Filed 2021-12-10 13:49
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 13:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:28
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 13:26
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report